First Turn Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-179,196
Closed -$7M 39
2025
Q1
$7M Buy
+179,196
New +$7M 1.41% 32